Kellie N. Smith
Cited by
Cited by
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
DT Le, JN Durham, KN Smith, H Wang, BR Bartlett, LK Aulakh, S Lu, ...
Science 357 (6349), 409-413, 2017
Neoadjuvant PD-1 blockade in resectable lung cancer
PM Forde, JE Chaft, KN Smith, V Anagnostou, TR Cottrell, MD Hellmann, ...
New England Journal of Medicine 378 (21), 1976-1986, 2018
Evolution of neoantigen landscape during immune checkpoint blockade in non–small cell lung cancer
V Anagnostou, KN Smith, PM Forde, N Niknafs, R Bhattacharya, J White, ...
Cancer discovery 7 (3), 264-276, 2017
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)
TR Cottrell, ED Thompson, PM Forde, JE Stein, AS Duffield, ...
Annals of Oncology 29 (8), 1853-1860, 2018
Dynamics of tumor and immune responses during immune checkpoint blockade in non–small cell lung cancer
V Anagnostou, PM Forde, JR White, N Niknafs, C Hruban, J Naidoo, ...
Cancer research 79 (6), 1214-1225, 2019
Redundant innate and adaptive sources of IL17 production drive colon tumorigenesis
F Housseau, S Wu, EC Wick, H Fan, X Wu, NJ Llosa, KN Smith, A Tam, ...
Cancer research 76 (8), 2115-2124, 2016
The mutation-associated neoantigen functional expansion of specific T cells (MANAFEST) assay: a sensitive platform for monitoring antitumor immunity
L Danilova, V Anagnostou, JX Caushi, JW Sidhom, H Guo, HY Chan, ...
Cancer immunology research 6 (8), 888-899, 2018
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer
V Anagnostou, N Niknafs, K Marrone, DC Bruhm, JR White, J Naidoo, ...
Nature cancer 1 (1), 99-111, 2020
Neoadjuvant nivolumab in early-stage, resectable non-small cell lung cancers.
JE Chaft, PM Forde, KN Smith, V Anagnostou, T Cottrell, JM Taube, ...
Journal of Clinical Oncology 35 (15_suppl), 8508-8508, 2017
Selective Induction of CTL Helper Rather Than Killer Activity by Natural Epitope Variants Promotes Dendritic Cell–Mediated HIV-1 Dissemination
RB Mailliard, KN Smith, RJ Fecek, G Rappocciolo, EJM Nascimento, ...
The Journal of Immunology 191 (5), 2570-2580, 2013
Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer. Cancer Discov. 2017; 7: 264–276. doi: 10.1158/2159-8290
V Anagnostou, KN Smith, PM Forde, N Niknafs, R Bhattacharya, J White, ...
CD-16-0828.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
Neoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer.
PM Forde, K Smith, JE Chaft, MD Hellmann, T Merghoub, JD Wolchok, ...
Journal of Clinical Oncology 34 (15_suppl), e20005-e20005, 2016
Compartmental analysis of T-cell clonal dynamics as a function of pathologic response to neoadjuvant PD-1 blockade in resectable non–small cell lung cancer
J Zhang, Z Ji, JX Caushi, M El Asmar, V Anagnostou, TR Cottrell, ...
Clinical Cancer Research 26 (6), 1327-1337, 2020
Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1
KN Smith, NJ Llosa, TR Cottrell, N Siegel, H Fan, P Suri, HY Chan, H Guo, ...
Journal for immunotherapy of cancer 7 (1), 1-8, 2019
Effective cytotoxic T lymphocyte targeting of persistent HIV-1 during antiretroviral therapy requires priming of naive CD8+ T cells
KN Smith, RB Mailliard, PA Piazza, W Fischer, BT Korber, RJ Fecek, ...
MBio 7 (3), 2016
Intratumoral adaptive immunosuppression and type 17 immunity in mismatch repair proficient colorectal tumors
NJ Llosa, B Luber, AJ Tam, KN Smith, N Siegel, AH Awan, H Fan, T Oke, ...
Clinical Cancer Research 25 (17), 5250-5259, 2019
Dendritic cells restore CD8+ T cell reactivity to autologous HIV-1
KN Smith, RB Mailliard, BB Larsen, K Wong, P Gupta, JI Mullins, ...
Journal of virology 88 (17), 9976-9990, 2014
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
JE Reuss, V Anagnostou, TR Cottrell, KN Smith, F Verde, M Zahurak, ...
Journal for immunotherapy of cancer 8 (2), 2020
Neoadjuvant nivolumab in resectable non-small cell lung cancer: Extended follow-up and molecular markers of response.
JE Reuss, KN Smith, V Anagnostou, J Zhang, M Zahurak, J Caushi, ...
Journal of Clinical Oncology 37 (15_suppl), 8524-8524, 2019
The impact of viral evolution and frequency of variant epitopes on primary and memory human immunodeficiency virus type 1-specific CD8+ T cell responses
NM Melhem, KN Smith, XL Huang, BA Colleton, W Jiang, RB Mailliard, ...
Virology 450, 34-48, 2014
The system can't perform the operation now. Try again later.
Articles 1–20